Hyalinizing trabecular tumour of the thyroid - Differential expression of distinct miRNAs compared with papillary thyroid carcinoma

Histopathology

Volumn 56, Issue 5, 2010, Pages 632-640

  Sheu, Sien Yi ^a   Vogel, Esther ^a   Worm, Karl ^a   Grabellus, Florian ^a   Schwertheim, Suzan ^a   Schmid, Kurt Werner ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Hyalinizing trabecular tumour; MiRNA; Papillary thyroid carcinoma; Thyroid

Indexed keywords

B RAF KINASE; MICRORNA; PROTEIN PATCHED; PROTEIN RET;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; HYALINIZING TRABECULAR TUMOR; MALE; MICRODISSECTION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TOXIC GOITER; TRANSCRIPTION REGULATION; UPREGULATION;

ADENOCARCINOMA, PAPILLARY; ADENOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GOITER, NODULAR; HUMANS; HYALIN; MICRORNAS; MUTATION; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS;

EID: 77950497367     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03526.x     Document Type: Article

References (44)

1. Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am. J. Surg. Pathol. 1987 11 583 591.
2. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Atlas of tumor pathology, 3rd edn.
3. Carney JA, Volante M, Papotti M, Asa S. Hyalinizing trabecular tumour. In DeLellis RA, Lloyd RV, Heitz P, Eng C eds. World Health Organization classification of tumours. Pathology & genetics. Tumours of endocrine organs.
4. Katoh R, Jasani B, Williams ED. Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 1989 15 211 224.
5. Papotti M, Volante M, Giuliano A et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am. J. Surg. Pathol. 2000 24 1615 1621.
6. Salvatore G, Chiappetta G, Nikiforov YE et al. Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur. J. Cancer 2005 41 816 821.
7. Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am. J. Surg. Pathol. 2000 24 1622 1626.
8. Xing M. BRAF mutation in thyroid cancer. Endocr. Relat. Cancer 2005 12 245 262.
9. Baloch ZW, Puttaswamy K, Brose M, LiVolsi VA. Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal 2006 3 17.
10. Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am. J. Surg. Pathol. 2008 32 1877 1889.
11. Gowrishankar S, Pai SA, Carney JA. Hyalinizing trabecular carcinoma of the thyroid gland. Histopathology 2008 52 529 531.
12. McCluggage WG, Sloan JM. Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 1996 28 357 362.
13. Molberg K, Albores-Saavedra J. Hyalinizing trabecular carcinoma of the thyroid gland. Hum. Pathol. 1994 25 192 197. (Pubitemid 24079640)
14. Cowland JB, Hother C, Gronbaek K. MicroRNAs and cancer. APMIS 2007 115 1090 1106.
15. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 2002 99 15524 15529.
16. Calin GA, Ferracin M, Cimmino A et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005 353 1793 1801.
17. Iorio MV, Ferracin M, Liu CG et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 65 7065 7070.
18. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005 435 834 838.
19. Mattie MD, Benz CC, Bowers J et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 2006 5 24.
20. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003 1 882 891.
21. Murakami Y, Yasuda T, Saigo K et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 25 2537 2545.
22. Takamizawa J, Konishi H, Yanagisawa K et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004 64 3753 3756.
23. Volinia S, Calin GA, Liu CG et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 2006 103 2257 2261.
24. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ III., Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod. Pathol. 2008 21 1139 1146.
25. He H, Jazdzewski K, Li W et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl Acad. Sci. USA 2005 102 19075 19080.
26. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 2008 93 1600 1608.
27. Pallante P, Visone R, Ferracin M et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer 2006 13 497 508.
28. Tetzlaff MT, Liu A, Xu X et al. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr. Pathol. 2007 18 163 173.
29. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 2006 91 3584 3591.
30. Musholt PB, Imkamp F, von Wasielewski R, Schmid KW, Musholt TJ. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas? Surgery 2003 134 881 889.
31. Chua EL, Wu WM, Tran KT et al. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. J. Clin. Endocrinol. Metab. 2000 85 2733 2739.
32. Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW. Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod. Pathol. 2007 20 779 787.
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 402 408.
34. Zhu Z, Ciampi R, Nikiforova MN, Gandhi M, Nikiforov YE. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J. Clin. Endocrinol. Metab. 2006 91 3603 3610.
35. Trovisco V, Vieira de Castro I, Soares P et al. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J. Pathol. 2004 202 247 251.
36. Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocr. Pathol. 2002 13 3 16.
37. Tallini G, Asa SL. RET oncogene activation in papillary thyroid carcinoma. Adv. Anat. Pathol. 2001 8 345 354.
38. Santoro M, Carlomagno F, Hay ID et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J. Clin. Invest. 1992 89 1517 1522.
39. Chiappetta G, Toti P, Cetta F et al. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hürthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J. Clin. Endocrinol. Metab. 2002 87 364 369.
40. Elisei R, Romei C, Vorontsova T et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J. Clin. Endocrinol. Metab. 2001 86 3211 3216.
41. Sheils OM, O'Leary JJ, Sweeney EC. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR. J. Pathol. 2000 192 32 36.
42. Wirtschafter A, Schmidt R, Rosen D et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 1997 107 95 100.
43. Nikiforov YE. RET/PTC Rearrangement - a link between Hashimoto's thyroiditis and thyroid cancer.or not. J. Clin. Endocrinol. Metab. 2006 91 2040 2042.
44. Galgano MT, Mills SE, Stelow EB. Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis. Am. J. Surg. Pathol. 2006 30 1269 1273.